Due to a production error, there was a mismatch in Figures 4D, 5D, 5E as published. The corrected figures appear below.
Additionally, the inactive video link in the Introduction section (paragraph 7) has been replaced with the following link: https://youtu.be/GKy3I-n3NRQ.
FIGURE 4
FIGURE 5
There were two typing errors in the Figure 3 legend, the correction appears below:
FIGURE 3
Patient 8 (A) hAM application, sutured on a collagen sponge. (B) Three days post-surgery. (C) Ten days post-surgery, with the reepithelialization on more than 
of the surgical site.
The publisher apologizes for this mistake. The original version of this article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Summary
Keywords
human amniotic membrane, osteonecrosis, oral mucosa, allograft, bisphosphonates, denosumab, antiangiogenic drugs
Citation
Frontiers Production Office (2022) Erratum: Tips and tricks and clinical outcome of cryopreserved human amniotic membrane application for the management of medication- related osteonecrosis of the jaw (MRONJ): A pilot study. Front. Bioeng. Biotechnol. 10:1058241. doi: 10.3389/fbioe.2022.1058241
Received
30 September 2022
Accepted
30 September 2022
Published
03 November 2022
Approved by
Frontiers in Editorial Office
Volume
10 - 2022
Updates
Copyright
© 2022 Frontiers Production Office.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Production Office, production.office@frontiersin.org
This article was submitted to Tissue Engineering and Regenerative Medicine, a section of the journal Frontiers in Bioengineering and Biotechnology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.